u/TherealCarbunc

3 theses · first seen Sep 4, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d
3d
1w
1m
3m
6m
1y

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$BEATr/pennystocksStock Infobullish
u/TherealCarbunc · 100d ago2 prior · awaiting results

BEAT - a growth story just getting started (FDA approved)

HeartBeam has a large addressable market (1.5M concierge, 2B patch, 40B platform opportunity) and needs only 30k patients for breakeven. Recent FDA approval, commercial partnerships (ClearCardio, Atelier Health), and strategic collaboration with Mount Sinai de-risk the investment. At $44.8M market cap and $0.81/share, insider confidence (CEO bought 750k shares) suggests meaningful upside potential over 2+ years.

At post $0.81Now $0.41-49.6% since posted19m ago
1d-2.8%
3d-6.4%
1w-4.3%
1m-22.7%
3m-47.3%
6m
1y
original post →
$NFEr/pennystocksDDbullish
u/TherealCarbunc · 298d ago2 prior · awaiting results
Long 1,800 shares of NFE

NFE, it's at the tipping point. (not pumping)

NFE is at a pivotal juncture with two critical catalysts: FOMB final approval for Puerto Rico operations (securing major revenue) and successful debt restructuring. With supportive bondholders already backing restructuring, 3+ years of runway secured, and shorts bleeding on 90%+ cost-to-borrow, the author believes upside odds exceed downside risk despite inherent turnaround risk.

Now $12.5818m ago
original post →
$FEMYr/pennystocksBullishbullish
u/TherealCarbunc · 317d ago2 prior · awaiting results

FEMY, original post removed due to no summary of the article posted

Femasys secured FDA approval to advance the final FemBloc trial phase with $12M in immediate financing and potential $58M total from convertible notes and warrants. The C-1 warrants exercisable at $1.10 establish a structural support level, combined with surging volume and decreasing shares available to short suggesting potential squeeze dynamics.

Now $2.5619m ago
original post →

End of results.